SCHEMBL4565322

SCHEMBL4565322

C[Sn](C)(C)c1ccccc1C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.56
ALOX15 P16050 1/20 0.56
KDM4E B2RXH2 4/20 0.48
HPGD P15428 4/20 0.48
CA12 O43570 3/20 0.48
CA1 P00915 3/20 0.48
CA2 P00918 3/20 0.48
CA4 P22748 3/20 0.48
CA7 P43166 3/20 0.48
CA9 Q16790 3/20 0.48
HMGB1 P09429 2/20 0.48
NAPRT Q6XQN6 2/20 0.48
CA6 P23280 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CA14 Q9ULX7 1/20 0.48
MAPT P10636 2/20 0.46
HDAC8 Q9BY41 1/20 0.46
AKR1C3 P42330 2/20 0.45
POLB P06746 1/20 0.45
HSD17B10 Q99714 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5952385 0.82 KDM4E (0.40) ALDH1A1ALOX15KDM4EHPGDCA12
SCHEMBL27419938 0.79 ALDH1A1 (0.48) ALDH1A1ALOX15KDM4EHPGDCA12
Phthalic Acid SCHEMBL28521655 0.78 ALDH1A1 (0.82) ALDH1A1ALOX15KDM4EHPGDCA12
Phthalic Acid SCHEMBL29358471 0.78 ALDH1A1 (0.82) ALDH1A1ALOX15KDM4EHPGDCA12
Phthalic Acid SCHEMBL8398555 0.78 ALDH1A1 (0.82) ALDH1A1ALOX15KDM4EHPGDCA12
Phthalic Acid SCHEMBL2777 0.78 ALDH1A1 (0.82) ALDH1A1ALOX15KDM4EHPGDCA12
Phthalic Acid SCHEMBL30100313 0.78 ALDH1A1 (0.82) ALDH1A1ALOX15KDM4EHPGDCA12
Phthalic Acid SCHEMBL7897915 0.78 ALDH1A1 (0.82) ALDH1A1ALOX15KDM4EHPGDCA12
Phthalic Acid SCHEMBL2561870 0.78 ALDH1A1 (0.82) ALDH1A1ALOX15KDM4EHPGDCA12
Phthalic Acid SCHEMBL27618507 0.78 ALDH1A1 (0.82) ALDH1A1ALOX15KDM4EHPGDCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3655438-A2 AGENTS, USES AND METHODS FOR TREATMENT H. Lundbeck A/S (DK) 2020-05-27 EP disclosed
WO-2019016247-A2 AGENTS, USES AND METHODS FOR TREATMENT H. LUNDBECK A/S (DK) 2019-01-24 WO disclosed
CN-108135986-A Molecule based on antibody for the truncated Asp421 epitope specificities of Tau and their purposes in diagnose and treat Tau diseases 纽约大学 2018-06-08 CN disclosed
CN-108137679-A To Tau's{p}Ser404 the epitopes selectively molecule based on antibody and their purposes in diagnose and treat Tau diseases 纽约大学 2018-06-08 CN disclosed
WO-2017070482-A2 PSMA TARGETED RADIOHALOGENATED UREAS FOR CANCER RADIOTHERAPY THE JOHNS HOPKINS UNIVERSITY (US) 2017-04-27 WO disclosed
EP-2072525-A1 New polypeptides having affinity for HER2 Affibody AB (SE) 2009-06-24 EP disclosed
EP-1259548-A1 ANTIBODY SPECIFIC FOR THE ED-B DOMAIN OF FIBRONECTIN, CONJUGATES COMPRISING SAID ANTIBODY, AND THEIR USE FOR THE DETECTION AND TREATMENT OF ANGIOGENESIS Eidgenössische Technische Hochschule Zürich (CH) 2002-11-27 EP disclosed
WO-2001062800-A1 ANTIBODY SPECIFIC FOR THE ED-B DOMAIN OF FIBRONECTIN, CONJUGATES COMPRISING SAID ANTIBODY, AND THEIR USE FOR THE DETECTION AND TREATMENT OF ANGIOGENESIS Eidgenössische Technische Hochschule Zürich (CH) 2001-08-30 WO disclosed